Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Correction for Fuster et al., Circulation 114 (7) 700-752.
« Previous Article | Table of Contents | Next Article »
Circulation. 2007;116:e137
Published online before print July 31, 2007, doi: 10.1161/CIRCULATIONAHA.107.184688
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
116/6/e137    most recent
CIRCULATIONAHA.107.184688v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow Anticoagulants
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Ablation/ICD/surgery
Right arrow Pacemaker

(Circulation. 2007;116:e137.)
© 2007 American Heart Association, Inc.

Correction

In the article by Fuster et al, "ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation)," which appeared in the August 15, 2006, issue of the journal (Circulation. 2006;114:700–752), the following corrections are needed to Table 18, page 733:
  1. This table should be retitled to "Pharmacological Treatment Before Cardioversion in Patients With Persistent AF: Effects of Various Antiarrhythimic Drugs on Immediate Recurrence, Outcome of Transthoracic Direct-Current Shock, or Both"
  2. Quinidine should be deleted from the table (Enhance Conversion by DC Shock and Prevent IRAF* column).
  3. The authors prefer that the third column be transposed to the fifth column.
  4. The recommendation class for the treatments with known efficacy (row 1, column 3) is IIa rather than I.

These errors have been corrected in the current online version of the article.





This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
116/6/e137    most recent
CIRCULATIONAHA.107.184688v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow Anticoagulants
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Ablation/ICD/surgery
Right arrow Pacemaker

Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.